爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

ideal trade links uab - beetametasoon+fusidiinhape - kreem - 1mg+20mg 1g 20g 1tk; 1mg+20mg 1g 15g 1tk

欧盟 - 爱沙尼亚文 - EMA (European Medicines Agency)

oncopeptides ab - melphalan flufenamide hydrochloride - mitu müeloomit - antineoplastilised ained - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

爱沙尼亚 - 爱沙尼亚文 - Ravimiamet

santen oy - deksametasoon+levofloksatsiin - silmatilgad, lahus - 1mg+5mg 1ml 5ml 1tk